State-of-the-Art Technology for Insulin Therapy in Type 1 Diabetes: Engineering and Cell-Based Approaches

The management landscape for Type 1 diabetes (T1DM) has changed drastically since the inception of insulin replacement therapies. Today, automated insulin delivery with closed-loop technology and advances in regenerative medicine can improve glycemic control, reduce patient disease burden and decrease insulin use. While these advances are driven by a clear medical need, innovations with cell-based replacement therapies and various technologies often add complexities to clinical trial design and implementation. This educational webinar will provide an overview of current T1DM devices and capabilities such as automated closed-loop control and cell-based replacement therapies, encapsulation strategies and cellular engineering. The presentation will also highlight current innovations, address existing gaps and discuss the inherent challenges of meeting requirements and timelines in the development of these unique devices and therapies. Join this informative presentation to hear from thought leaders in the field as they share their applicable research experiences and explore the current state of technologies and regenerative medicine.